Results 161 to 170 of about 51,767 (241)

Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis. [PDF]

J Cell Mol Med
Kaplan D, Christian E, Valent J, Anwer F, Mazzoni S, Samaras C, Williams L, Nakashima M, Raza S, Hanna M, Lazarus HM, Khouri J.   +11 more
europepmc   +1 more source

The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients [PDF]

, 2014
X M Huang, Qizhang Wang, Shan Jiang, Wei Chen, Caihong Zeng, Zhihong Liu   +5 more
openalex   +1 more source

Astrocyte–vascular interplay in Alzheimer's disease pathology: Novel insights into stage‐specific biomarkers and therapeutic targets

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract INTRODUCTION We examined how neurovascular and astrocytic response alter cognition in Alzheimer's disease (AD). METHODS Cognitive scores, biomarkers of AD and astrocytic activation, vascular factors, and brain structure data from 693 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants were analyzed using analysis of covariance ...
Zehu Sheng, Yuhao Chen, Ming Chen, Shuyu Liang, Jingyi Wang, Yingxi Chen, Rengui Li, Boyuan Xia, Kangjinyuan Gou, Siyuan Liu, Alzheimer's Disease Neuroimaging Initiative, Weihua Yu, Yang Lü   +12 more
wiley   +1 more source

Advances in Synchrotron Radiation‐Based Vacuum‐Ultraviolet Circular Dichroism for Biomolecular Structural Analysis

Chemistry – An Asian Journal, Volume 21, Issue 2, 28 January 2026.
Vacuum‐ultraviolet circular dichroism spectroscopy using synchrotron radiation is operated at the Research Institute for Synchrotron Radiation Science (HiSOR), Hiroshima University. By combining the circular dichroism technique with bioinformatics, molecular dynamics, and linear dichroism, the spectral analysis methods have been advanced, enabling ...
Koichi Matsuo, Satoshi Hashimoto, Ryota Imaura, Mohamed I. A. Ibrahim   +3 more
wiley   +1 more source

AL Amyloidosis: Current Treatment and Outcomes. [PDF]

Adv Hematol
Locke M, Nieto M.
europepmc   +1 more source

COEXISTENCE OF POLYCYSTIC KIDNEY DISEASE AND AL-AMYLOIDOSIS IN A PATIENT WITH NEPHROTIC SYNDROME

, 2023
A. Simonyan, N. Alexanyan, Astghik Voskanyan   +2 more
openalex   +1 more source

Euglycemic Ketoacidosis Induced by Dapagliflozin in a Non‐Diabetic Patient With Cardiac Amyloidosis

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Dapagliflozin, though beneficial in heart failure, can rarely cause euglycemic ketoacidosis even in non‐diabetic patients. Clinicians should maintain a high index of suspicion for metabolic acidosis in patients on SGLT2 inhibitors presenting with unexplained illness, regardless of blood glucose level.
Salhamoud Abdelfatah Saleh Hamoud, Ellie Harding   +1 more
wiley   +1 more source

Atypical Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis. [PDF]

Cureus
Faraci J, Connor JA, Randhawa S.
europepmc   +1 more source

An updated AL-Base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis

Gareth J. Morgan, Allison Nau, Sherry Wong, Brian Spencer, Yun Shen, Axin Hua, Matthew J. Bullard, Vaishali Sanchorawala, Tatiana Prokaeva   +8 more
openalex   +1 more source

Intracellular Catalytic Photooxygenation of α‐Synuclein Amyloid

ChemistryEurope, Volume 4, Issue 1, January 2026.
Amyloid‐selective catalytic photooxygenation reduces amyloid toxicity, aggregation tendencies, and seeding activities. Achieving therapeutic catalysis for intracellular amyloids is challenging due to conflicting oxygenation and reductive cellular environments.
Atsushi Iwai, Youhi Hwang, Hiroki Umeda, Taka Sawazaki, Ikumi Tomizawa, Maiko Ono, Makoto Higuchi, Youhei Sohma, Yukiko Hori, Taisuke Tomita, Harunobu Mitsunuma, Motomu Kanai   +11 more
wiley   +1 more source